期刊文献+

淫羊藿饮片杂质问题的研究与探讨 被引量:2

Research and discussion on impurity problems in Epimedium cut crude drug
原文传递
导出
摘要 目的:探讨淫羊藿饮片中的杂质问题。方法:检查15批次淫羊藿饮片中各类杂质的含量,并测定淫羊藿饮片各部位中朝藿定A、朝藿定B、朝藿定C、淫羊藿苷和宝藿苷I五种黄酮类成分的含量。结果:15批次淫羊藿饮片杂质平均含量为23.66%,其中非药用部分茎占18.39%,柄占4.22%,其它杂质异物占1.05%,并且茎、柄中5种黄酮类成分的含量为淫羊藿叶中含量的1/10。结论:淫羊藿饮片中茎、柄杂质的大量存在直接导致了饮片整体质量的降低,因此建议在2010版《中国药典》质量标准制订中,将淫羊藿药材的药用部位规定为"干燥叶片",从药材源头开始杜绝非药用部分茎、柄的存在,从而提高淫羊藿药材和饮片的整体质量,保证饮片的纯净度和投药量的准确度,进而确保临床疗效。 Objectve: To discussion the impurity problems in Epimedium cut crude drug. Methods: All kinds of impurity content were investigated in 15 batches Epimedium cut crude drug, and the five flavonoids content were determined in every part. Results: The average impurity content of 15 batches Epimedium cut crude drug was 23.66%. Of the total, stalk reached 18.39%, leafstalk reached 4.22%, and other foreign matters was 1.05%. The five flavonoids content in leaves was l0 times of the content in leafstalks and stalks. Conclusion: The generous leafstalks and stalks impurity have leaded to lower the total body mass of Epimedium cut crude drug. Therefore we suggested that the drug use part of Epimedium medicinal substances should be defined dry leaf in Chinese Pharmacopeia 2010 edition, which can eliminate leafstalks and stalks from source head. This can improve total body mass of medicinal substances and cut crude drug, and ensure the clean degree of cut crude drug and the accurate degree of dosage, thus to ensure clinical curative effect.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2010年第12期1964-1967,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 <中国药典>2010版一部标准研究项目(No.YS-240) 国家自然基金资助项目(No.30572372 30973944)~~
关键词 淫羊藿饮片 杂质 黄酮类成分 Epimedium cut crude drug Impurity Caulis flavonoibs content
  • 相关文献

参考文献5

二级参考文献16

  • 1蔡曼玲,季晖,李萍,王明权.5种淫羊藿黄酮类成分对体外培养成骨细胞的影响[J].中国天然药物,2004,2(4):235-238. 被引量:45
  • 2张艺,肖崇厚,孟宪丽,钟国跃.HPLC法测定川产淫羊藿属植物的淫羊藿甙含量[J].中国中药杂志,1995,20(5):265-266. 被引量:25
  • 3张艺,肖崇厚,孟宪丽,刘永源,钟国跃.8种川产商品淫羊藿总黄酮的含量测定及资源利用[J].中国中药杂志,1995,20(4):201-202. 被引量:43
  • 4史万忠,徐德生,刘力,刘瑾.30批市售淫羊藿的质量分析[J].中国实验方剂学杂志,2006,12(7):6-7. 被引量:9
  • 5LIU T Z, CHEN C Y,YIN S J,et al.Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21Cip1 and p27Kip1. Food and Chemical Toxicology,2006 (44) :227-235
  • 6Meng F H, Li Y B, Xiong Z L, et al.Osteoblastic proliferative activity of Epimedium brevicomum Maxim.Phytomedicine,2005 (12): 189-193
  • 7徐世明,中草药,1985年,16卷,10期,10页
  • 8中华人民共和国卫生部药典委员会编. 中华人民共和国药典,2000版(一部)[M]. 北京:化学工业出版社,2000. 附录49.
  • 9Liu TZ, Chen CY, Yin SJ, et al .Molecular mechanism of cell cycle blockage of hepatoma SK - Hep- 1 cells by Eplmedin C through suppression of mitogen - activated protein kinase activation and increased expression of CDK inhibitors p21Cip1 and p27Kip1[J] .Food Chem Toxicol, 2006,44: 227.
  • 10Meng FH, Li YB,Xiong ZL, et al. Osteoblastic proliferative activity of Epimedium brevicornum Maxim[J]. Phytomedicine , 2005,12:189.

共引文献66

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部